Development
BlackRock Health Sciences Trust
BME
$36.05
$0.571.61%
| Weiss Ratings | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C+ | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Company Info | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | BlackRock | |||
| Manager/Tenure (Years) | Erin Xie (20), Kyle McClements (12), Christopher M. Accettella (12), 1 other | |||
| Website | http://www.blackrock.com | |||
| Fund Information | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | BlackRock Health Sciences Trust | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Mar 28, 2005 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.21% | |||
| Dividend | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.16% | |||
| Asset Allocation | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.73% | |||
| Stock | 99.07% | |||
| U.S. Stock | 95.00% | |||
| Non-U.S. Stock | 4.07% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.21% | |||
| Price History | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -9.62% | |||
| 30-Day Total Return | -11.85% | |||
| 60-Day Total Return | -11.61% | |||
| 90-Day Total Return | -6.34% | |||
| Year to Date Total Return | -6.34% | |||
| 1-Year Total Return | -7.47% | |||
| 2-Year Total Return | 2.24% | |||
| 3-Year Total Return | 0.08% | |||
| 5-Year Total Return | 43.70% | |||
| Price | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | $38.33 | |||
| 1-Month High Price | $40.19 | |||
| 52-Week Low Price | $36.92 | |||
| 52-Week Low Price (Date) | Dec 19, 2024 | |||
| 52-Week High Price | $42.41 | |||
| 52-Week High Price (Date) | Aug 30, 2024 | |||
| NAV | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $41.02 | |||
| 1-Month Low NAV | $41.02 | |||
| 1-Month High NAV | $43.32 | |||
| 52-Week Low NAV | $40.83 | |||
| 52-Week Low NAV (Date) | Dec 19, 2024 | |||
| 52-Week High NAV | $46.00 | |||
| 52-Week High Price (Date) | Sep 02, 2024 | |||
| Beta / Standard Deviation | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Standard Deviation | 11.46 | |||
| Balance Sheet | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 538.55M | |||
| Operating Ratios | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.10% | |||
| Turnover Ratio | 29.00% | |||
| Performance | BME-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 5.98% | |||
| Last Bear Market Total Return | -5.52% | |||